New tools for the investigations of Neuro-AIDS at a molecular level: The potential role of data-mining. by Orlando, Bruno et al.
UCLA
UCLA Previously Published Works
Title
New tools for the investigations of Neuro-AIDS at a molecular level: The potential role of 
data-mining.
Permalink
https://escholarship.org/uc/item/07w4m5jz
Journal
Bioinformation, 9(12)
ISSN
0973-2063
Authors
Orlando, Bruno
Giacomelli, Luca
Chiappelli, Francesco
et al.
Publication Date
2013
DOI
10.6026/97320630009656
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
 
open access www.bioinformation.net Review 
 Volume 9(12)  
 
ISSN 0973-2063 (online) 0973-8894 (print)   
Bioinformation 9(12): 656-658 (2013) 656  © 2013 Biomedical Informatics 
 
New tools for the investigations of Neuro-AIDS at a 
molecular level: The potential role of data-mining 
 
 
Bruno Orlando1, 2, Luca Giacomelli3, Francesco Chiappelli4* & André Barkhordarian4 
 
 
1Laboratories of Biophysics and Nanobiotechnology, Department of Medical Science, University of Genova, Italy; 2Department of 
Surgery, University of Pisa, Italy; 3Free researcher, Milan, Italy; 4UCLA School of Dentistry, CHS63-090; Los Angeles CA, 90095-
1668; Francesco Chiappelli – Email: fchiappelli@dentistry.ucla.edu; Phone: 310-794-6625; Fax: 310-794-7134; *Corresponding author 
 
 
Received April 24, 2013; Accepted April 30, 2013; Published July 12, 2013 
 
 
Abstract: 
Cognitive impairment represents the most significant and devastating neurological complication associated with HIV infection. 
Despite recent advances in our knowledge of the clinical features, pathogenesis, and molecular aspects of HIV-related dementia, 
current diagnostic strategies are associated with significant limitations. It has been suggested that the use of some biomarkers may 
assist researchers and clinicians in predicting the onset of the disease process and in evaluating the effects of new therapies. 
However, the large number of chemicals and metabolic pathways involved in the pathogenesis of neurodegeneration, warrants the 
development of novel approaches to integrate this huge amount of data. The contribution of theoretical disciplines, such as 
bioinformatics and data-mining, may be useful for testing new hypotheses in diagnosis and patient-centered treatment 
interventions. 
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Molecular mechanisms of cognitive impairment in patients 
with HIV infection: 
HIV encephalitis (HIVE) is the common pathologic correlate of 
cognitive impairment in patients with HIV infection. In the 
central nervous system (CNS) of these patients, brain 
mononuclear phagocytes are reservoirs for persistent viral 
infection. HIV-infected monocytes/macrophages release 
several viral proteins, some of which activate glial cells such as 
microglia and astrocytes to release chemokines, cytokines and a 
number of soluble neurotoxic substances. Neurotoxins, in 
conjunction with secreted HIV proteins, damage the synapto-
dendritic axis of neurons, resulting in neuronal dysfunction 
and cell loss via apoptosis [1]. Previous studies already 
reported that HIV proteins abnormally activate the CDK5 [2] 
and GSK3β [3] cascades. The deregulation of the GSK3β 
enzyme could contribute to HIV-induced neuronal apoptosis. 
In addition, HIV proteins might activate the CDK5 pathway 
and subsequently upset the various actions that CDK5 
regulates, including synapse formation and plasticity and 
neurogenesis. Past studies also speculated that in patients with 
cognitive impairment, the neurodegenerative process might 
correlate with an altered expression of neurotrophic factors 
such as vascular endothelial growth factor (VEGF), interleukin-
8 (IL-8), and fibroblast growth factors (FGFs). FGFs exert their 
effects via receptor tyrosine kinases, leading to inactivation of 
GSK3β through phosphorylation of a serine residue. Other 
growth factors, such as insulin growth factor-1 (IGF-I), 
epidermal growth factor (EGF) and platelet-derived growth 
factor (PDGF), causes a similar inhibition of GSK3β activity by 
inducing phosphorylation [2]. 
 
CDK5 is a protein kinase with postmitotic activity that 
phosphorylates cytoskeletal proteins (MAP1b, tau, NF, nestin, 
DCX), synaptic proteins (PSD95, synapsin, cadherin) and 
transcription factors (MEF2). Its activity is regulated primarily 
by the metabolism of the activating proteins p35 and p39. A 
recent investigation indicates that p25, a truncated form of p35, 
accumulates in neurons of patients with neurodegenerative 
diseases. Binding of p25 to CDK5 constitutively activates 
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CDK5, changes its cellular location and alters its substrate 
specificity. Expression of the p25/CDK5 complex results in 
abnormal phosphorylation of toxic substrates that induces 
cytoskeletal disruption, morphological degeneration and 
apoptosis [4].  
 
Understanding the molecular pathology of cognitive 
impairment in patients with HIV infection: current concerns 
and the need of new investigation tools: 
As described above, several inflammatory molecules including 
cytokines, chemokines, growth factors, and excitatory 
compounds are associated with brain inflammation and 
damage. Genomics and proteomics could be applied to reach a 
deeper understanding of the molecular mechanisms underlying 
complex multifactorial disorders. However, mass-scale 
molecular genomics and proteomics suffer from some pitfalls: 
gene and protein expression is not significant per se, but only if 
inserted in a detailed cross-talk of molecular pathways and 
gene/gene, gene/protein and protein/protein interactions. 
Many diseases, including HIVE, are complex, polygenic 
disorders. In these diseases, the etiology is not attributed to the 
expression of a single gene or to the encoded protein, but it is 
spread over several different genes, each having a modest 
effect. However, although each gene has a small effect, the 
overall effect of all the genes and of all the encoded proteins 
involved may be substantial. Therefore, the pathophysiology of 
complex diseases is characterized by the involvement of 
various biologic pathways. A simple variation in expression of 
a single gene or of the encoded protein is not meaningful per 
se, but only if put in a proper framework of interactions (i.e. 
physical interaction of different molecules, involvement in the 
same metabolic pathway, and co-expression in microarray 
studies). The analysis of the complex network of connections 
between genes/proteins may allow the identification of 
potential molecular markers and targets [5].  
 
The study of interaction networks requires the systematization 
and the analysis of a huge amount of information emerging 
from experimental studies, but a complete experimental 
analysis of all the molecules involved in a given process, 
including both genes/proteins and small molecules, appears a 
challenging task. For instance, the greatest part of genes 
displayed on an array is often not directly involved in the 
cellular process being studied. Commercial arrays with a lower 
number of genes – usually 150–200 – are currently available, 
but the genes displayed are usually once again chosen without 
a precise consideration of the particular target of the study [6]. 
The contribution of theoretical disciplines, such as 
bioinformatics and data-mining, is therefore required to 
integrate this huge amount of data. Bioinformatics can become 
an added value in this context [6]. This discipline is defined as 
the application of information technology to the field of 
molecular biology, via the development of original algorithms 
[7]. Another discipline playing an important role in the analysis 
of genomics/proteomics experiments is data mining, i.e. 
extracting patterns from data, thus developing new information 
from previous knowledge [8]. With these methods, a further 
simplification of complex information emerging from 
genomics/proteomics experiments becomes possible. Properly 
combined with bioinformatics techniques and algorithms, data 
mining may allow to draw a simpler, but at the same time 
powerful picture of complex amount of data.  
Novel approaches for the analysis of the molecular events 
underlying neurodegeneration in HIV-infected patients: 
Bioinformatics and data-mining can play a central role in the 
analysis and interpretation of genomic and proteomic data. In 
particular, these disciplines may be useful to further clarify the 
pathophysiology of complex diseases, which are characterized 
by various biologic pathways, dependent upon the contribution 
of a large number of genes forming complex networks of 
interactions [7, 8]. We (FC in Shapshak et al, 2006) provided a 
preliminary description of the molecular mechanisms 
underlying these processes using expression and gene 
annotation data [9]. This information has been stored in a user 
friendly, online database that, when made available in the 
public domain, will enable scientists to retrieve biochemical 
and physiological information on neuro-degeneration in HIV-
infected patients. They are also developing methods to 
structure anatomical information (location where specific 
biochemical reactions occur) so that essential structural features 
are included along with the topological attributes [9]. 
 
 
Figure 1: Flow chart of the leader gene approach. 
 
Recently, another data-mining method, defined as the “Leader 
Gene approach” have been proposed (Figure 1) [6, 10]. This 
mining algorithm is based on the systematic search for the 
genes involved in a given process; the interaction among these 
genes are then calculated and genes are ranked according to the 
number and the confidence of all experimentally established 
interactions, as derived from free Web-available databases, 
such as STRING (Search Tool for the Retrieval of Interacting 
Genes, Heidelberg, Germany). Genes in the highest rank are 
defined as „„leader genes‟‟, since they can be preliminarily 
supposed to play an important role in the analyzed process. 
These genes may become potential targets for a targeted 
experimentation, which may be simpler than mass-scale 
molecular genomics and, at the same time, powerful [5, 6, 10]. 
The Leader Gene approach was applied to different cellular 
processes and pathological conditions, such as the human T 
lymphocyte cell cycle, human kidney transplant and 
periodontitis [5, 6, 10]; the results were integrated with a 
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targeted experimental analysis, to draw an overall picture of 
these processes. 
 
First, a preliminarily set of genes with an established role in a 
specific process is identified by an iterative search of large-scale 
gene databases (PubMed, GeneBank, Geneatlas, Genecards), 
using several keyword-based searches and the official HGNC 
nomenclature. Second, the preliminary set of genes is expanded 
using the STRING database, excluding text-mining-derived 
interactions, to identify genes linked to those playing an 
established role in the process under study, and therefore 
potentially involved in it. Only interactions with a confidence 
score >0.9, as given by STRING, are considered. Results are 
then filtered to discard false positives via a keyword-based 
query in PubMed, until no new genes are retrieved. Third, the 
interactions between all the genes identified are mapped using 
STRING. This database gives a combined association score to 
each gene-gene interaction, representing its strength. The 
combined association scores referring to each single gene are 
then summed to obtain a weighted number of links (WNL). 
Fourth, genes are clustered (hierarchical and K-means 
algorithms) according to their WNL. The genes belonging to the 
highest class are defined as leader genes. This analysis could 
further confirm that data-mining of existing databases may 
represent a starting point to improve our knowledge about 
cellular processes and diseases, to formulate new hypotheses 
and to plan targeted experimentation [6]. In particular, the 
analysis of gene interaction maps and the ranking of genes 
according to their interconnections might help in identifying 
new targets for dedicated experimental analyses, which may 
confirm or discard each hypothesis and suggest potential risk 
factors and therapy targets [6]. Taken together, and in the 
current context of translational effectiveness, the utilization of 
the best available data in specific clinical settings for patient-
centered care, the cutting-edge concepts we have discussed 
here confirm that bioinformatics and data-mining will have an 
increasingly important role in the integration of translational 
research findings for evidence-based diagnosis and prognostic 
interventions for patients with Neuro-AIDS, which require new 
and improved bioinformation dissemination structures, such as 
those we have proposed previously [11-13]. 
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